Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-14

FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for dorzolamide hydrochloride and timolol maleate ophthalmic solution from Bausch & Lomb Incorporated. It is indicated t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution (Dorzolamide hydrochloride and timolol maleate)

Snippet

SUPPL AP for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)